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Background: Enhanced recovery programmes in total knee arthroplasty are well established. Post-operative knee
swelling is common and impairs early post-operative function. The use of a short-stretch, inelastic compression
bandage is hypothesised to reduce knee swelling and improve pain and early function. A study was designed to
test feasibility with a view to informing a larger, future trial and to provide preliminary data.
Methods/design: This is a randomised controlled feasibility study. Fifty consecutive patients selected for
primary total knee arthroplasty will be enrolled in the trial. Patients with a BMI >35, latex allergy or neurological
or peripheral vascular disease are excluded. Patients are randomised by distance randomisation to receive a
compression bandage for 24 hours after surgery or a standard wool and crepe bandage. The bandages are
applied by one of two consultant surgeons who have had training with their application. Knee swelling, range
of motion and pain scores will be compared pre-operatively and at day 1, day 2 and at 6 weeks between
groups. The Oxford knee score and EQ-5D health status will be compared pre-operatively and at 6 months
between groups. Recruitment rates, retention rates, resource allocation, completeness of data collection, and
tolerance and complications with the compression bandage are recorded. Descriptive statistics are used to
calculate a standard deviation for post-operative knee swelling in the groups and to perform a power calculation
incorporating anticipated patient retention rates to inform a future trial. Preliminary data will be analysed using
the independent samples t-test for equal distributions and the Mann-Whitney U for unequal distributions with
the significance denoted at P <0.05.
Discussion: Enhanced recovery programmes have revolutionized the management of total knee arthroplasty.
There is a paucity of clinical data regarding the efficacy of compression bandages. Large, randomised controlled
trials are uncommon in orthopaedic surgery. The results of this study will provide feasibility and preliminary data
prior to the construction of a larger, multicentre study.
Trial registration: The study was registered with Current Controlled Trials (ISRCTN86903140) on 30 May 2013.
Keywords: Knee replacement, Arthroplasty, Compression bandage, Enhanced recovery, Fast track* Correspondence: t.m.brock@doctors.org.uk
1NIHR academic clinical fellow and orthopaedic registrar, Wansbeck General
Hospital, Woodhorn Lane, Northumberland NE63 9JJ, UK
Full list of author information is available at the end of the article
© 2015 Brock et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Brock et al. Trials  (2015) 16:87 Page 2 of 7Background
Total knee replacement is a common and highly suc-
cessful operation in the management of osteoarthritis.
The evolution of enhanced recovery programmes over
the last 15 years has reduced hospital stay and morbid-
ity, without increasing readmission rates [1,2].
Post-operative knee swelling is a common problem fol-
lowing total knee replacement. This is largely due to
intra-articular bleeding and inflammation of periarticular
tissues [3]. Knee swelling results in decreased functional
performance as a result of quadriceps weakness [4] and
as a result of arthrogenic reflex inhibition due to pain
[5]. The resulting decrease in functional performance
can delay rehabilitation and affect length of stay and
patient-reported outcomes [6,7]. Excessive knee swelling
is also associated with increased rates of dehiscence and
infection in surgical wounds [8].
Various techniques have been utilised to reduce
intra-articular bleeding, including modification of sur-
gical technique [9], tourniquets [10], medication [11]
and rehabilitation protocols [12]. Post-operative methods
include the use of a cold compress [13], cryotherapy [14],
elastic bandaging [15] and compression bandages [16,17].
However, there is a paucity of clinical data regarding
the use of compression bandages with heterogeneous
methodology. Andersen et al. utilised a compression
bandage consisting of a double layer of soft padding
and an outer elastic adhesive dressing compared with
standard bandage in a randomised controlled trial of
48 patients [16]. The bandage was combined with
local anaesthetic infiltration. The intervention group
had significantly reduced pain at 8 hours compared to
a control group. There was no difference in length of
stay. As this was an acute pain study, range of motion,
swelling and quality of life were not assessed.
A randomised controlled trial of 60 patients undergo-
ing unicondylar knee arthroplasty found no difference in
swelling and post-operative pain in patients who re-
ceived a modified Robert-Jones type bandage compared
to a standard wool and crepe bandage when assessed at
24 h and 48 h post-operatively [18]. Conversely, a non-
randomised study of 150 patients undergoing total knee
arthroplasty found a compression bandage to be advan-
tageous, with improvements in total range of motion
and length of stay when compared to wool and crepe
bandages [12].
Munk et al. randomised 88 patients to receive either
an elastic medical compression stocking or no stocking
for 4 weeks after total knee arthroplasty [19]. The main
outcome measures were knee swelling, knee flexion and
pain scores. The study did not find any clinical effect be-
tween the two groups. However, the stocking was ap-
plied the day after surgery when it was documented that
70% of the swelling had already occurred.Therefore, the efficacy of compression bandage ther-
apy after total knee arthroplasty remains unclear due to
varying methodology and small sample sizes. The effi-
cacy of compression bandaging in the treatment of ven-
ous ulcers and lymphoedema is encouraging [20,21].
With regard to total knee arthroplasty, there are two
main mechanisms that cause post-operative swelling.
The first is an increase in vascular permeability as a
result of the release of histamine and histamine-like sub-
stances causing the capillary network to allow more elec-
trolytes and plasma proteins into the tissues as a direct
response to trauma [8]. This causes an imbalance in
homeostasis and a net movement of fluid into the inter-
stitial space from the vascular space. This response is
short lived but deleterious. Secondly, vascular injury
from the surgery causes bleeding, which leaks into the
tissues until plugged by thrombus [8]. Whilst the mecha-
nisms of compression therapy are poorly understood, it
is believed that the application of external compression
causes a decrease in hydrostatic pressure by aiding ven-
ous return as a result of moving blood from the superfi-
cial to deep venous system and by improving the efficacy
of the calf muscle pump. This allows movement of fluid
from the interstitial space. It also aids lymphatic drain-
age, and a resultant hyperaemic response improves arter-
ial blood flow [22]. With regard to the type of bandage,
inelastic compression bandages have been found to have
a low, tolerable resting pressure but a more effective
activation of the deep venous system and calf muscle
pump with ambulation compared to the elastic coun-
terparts [23].
It is hypothesised that the use of a compression ban-
dage in total knee arthroplasty will therefore reduce
lower leg swelling by improving venous return post-
operatively. This improvement will improve knee exten-
sion strength and reduce pain inhibition, allowing earlier,
effective rehabilitation and an improvement in length of
stay and patient reported outcome measures.
To test this hypothesis, a large, randomised controlled
trial is required. The aim of this current study is to test
the feasibility of the methodology and gather data to in-
form a larger future trial. The secondary objective is to
perform a small-scale trial to provide preliminary data.
Methods/design
The study is a prospectively enrolled, randomised con-
trolled feasibility study conducted at two hospital sites
within the Northumbria Healthcare NHS Foundation
Trust. The study has been approved by the Newcastle
and North Tyneside Research Ethics Committee (13/NE/
0137), and all patients will provide written, informed
consent. The study has been registered with Current
Controlled Trials (ISRCTN86903140) and is sponsored
by Northumbria Healthcare NHS Foundation Trust.
Figure 1 Standard wool and crepe bandage.
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A total of fifty consecutive patients selected for total
knee arthroplasty will be enrolled in the study. Due to
insufficient data in the literature to determine a clinically
relevant change in outcome measures, the sample size
is based on the ability to calculate a mean and stand-
ard deviation in these measures to allow an accurate
power calculation for the future trial. The sample size
conforms to guidelines on feasibility studies in the lit-
erature and is large enough to additionally provide
preliminary data [24].
Study duration
The study started recruiting in November 2013, and data
collection is expected to finish in December 2014. This
timeframe is based on 2 months initial set-up, 6 months
recruitment and 6 months follow-up. Six months re-
cruitment assumes approximately two patients per week
or one patient per operating surgeon. Based on joint
registry data, this assumes an approximate inclusion rate
of 66% based on the two operating surgeons’ caseloads.
Inclusion /exclusion criteria
The inclusion criteria for the study include (i) primary
total knee arthroplasty for osteoarthritis, (ii) age over 18,
and (iii) able to provide written, informed consent.
Exclusion criteria include (i) peripheral vascular dis-
ease characterised by an ABPI <0.8, (ii) peripheral neur-
opathy, (iii) BMI >35, (iv) revision knee arthroplasty, (v)
unicondylar or patellofemoral joint knee arthroplasty or
(vi) high dose anticoagulation. The majority of criteria
have been established to reduce confounding variables
associated with post-operative swelling in knee arthro-
plasty or due to contraindications with the compression
bandage.
Consent
The patient is given an information sheet regarding the
trial after being listed for knee joint arthroplasty. Any
questions are answered by a good clinical practice
(GCP)-trained research nurse before the patient is con-
sented into the trial. The patient is given at least 24
hours to make this decision following initial supply of
information.
Patient allocation
The patient is randomised to the intervention on the
day of surgery by electronic distance randomisation
using the website www.sealedenvelope.com. The ran-
domisation process is done in permuted blocks to allow
even balancing of the groups. Patients will be allocated
to the standard care group or the compression bandage
group as outlined below.Standard care group
Patients undergo primary total knee arthroplasty under
the care of one of two consultant orthopaedic surgeons
(SM, MR). Surgery is with either general anaesthesia or
spinal anaesthesia and sedation. Intravenous antibiotics
(gentamicin 3 mg/kg and teicoplanin 400 mg iv) and
tranexamic acid (30 mg/kg iv up to 2.5 g) are adminis-
tered and a tourniquet is used. A Nexgen cruciate
retaining total knee arthroplasty is routinely used for
primary total knee arthroplasty in the trust (Zimmer,
Swindon, United Kingdom) with Palacos R + G bone ce-
ment (Heraeus Medical, Newbury, United Kingdom).
Intra-operative periarticular injections of 80 ml 0.125%
bupivacaine are infiltrated, and a further 20 ml 0.125%
bupivicaine bolus is given via intra-articular wound cath-
eter after wound closure. The skin is closed using surgi-
cal skin clips, which are removed at 10 to 14 days
post-operatively. A hydrocolloid dressing (Aquacel surgi-
cal, Convatec Ltd, Flintfield, UK) is used for the wound.
Standard bandaging consists of a soft inner layer
(Soffban, BSN Medical Ltd, Brierfield, UK) applied from
10 cm below to 10 cm above the patella with a 50%
overlap of bandage, followed by a similar outer layer of
crepe bandage (BSN Medical Ltd, Brierfield UK) prior to
deflation of the tourniquet (Figure 1).
The bandage and wound catheter are removed at 24
hour leaving the hydrocolloid wound dressing in-situ.
This dressing stays on until the clips are removed at 10
to 14 days and prevents any contamination of the
wound, for example, during the knee swelling measure-
ments. A cryocuff is used after 24 hours.
Physiotherapy starts on the day of surgery. Focus ini-
tially is on first time mobilisation, quadriceps strength-
ening exercises and passive full extension. Following
this, patients are seen at least twice daily by the physio-
therapist, and range of motion, gait re-education and
lower limb strengthening techniques are employed every
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weekly in an outpatient physiotherapy class if required
until they are independently walking, have full passive
extension and a range of motion in the knee from 0 to
90 degrees.
Intervention group
The compression bandage is applied over the hydrocol-
loid surgical wound dressing. A soft inner layer (Soffban,
BSN Medical Ltd, Brierfield, UK) is applied from the
toes to the groin on the affected leg with a 50% overlap
of bandage. Following this the outer compressive layer
bandage (Actico bandage, Activa Healthcare Ltd, UK) is
applied firmly over the top, again with a 50% overlap of
bandage. The bandage is pulled to full stretch before it is
wrapped around the leg to ensure adequate compression
in the application (Figure 2). A short-stretch, inelastic
compressive bandage has been chosen because it is tol-
erable overnight due to its low resting pressure, yet pro-
duces high pressure with movement to greatly improve
the efficacy of the calf muscle pump. The bandage is ap-
plied from the toes upwards. The application of bandage
from thigh to groin requires removal of the tourniquet
first and so the leg is kept elevated until the bandaging
is complete. To ensure homogeneity in bandage applica-
tion, the operating surgeons were shown a training video
on correct application of the bandage and were given a
tutorial on bandage application with real life bandage
application and feedback. Correct bandage application
was checked throughout the trial by the lead author and
research nurse. The bandage is removed at 24 hours
post-surgery leaving the hydrocolloid wound dressing




Processes key to the future study will be analysed. Re-
cruitment, retention and refusal rates will be calculated.
The proportion of patients undergoing primary totalFigure 2 Short-stretch, inelastic compression bandage.knee arthroplasty who did not meet the eligibility cri-
teria will also be calculated to ensure this is not too
restrictive.
Resource allocation will be determined by calculating
the time required for the recruitment and follow-up
process. This will allow accurate resource allocation with
regard to clinical research nurse and physiotherapy
input.
Bandaging skill acquisition training video, ease of ap-
plication and tolerance of the compression bandage will
be determined from the operating surgeons and patients.
Potential adverse risks associated with the use of the
compression bandage such as pain, wound dehiscence
and blistering will be recorded and rates calculated.
Qualitative feedback will be provided by the research
team and clinical staff to determine any potential prob-
lems associated with the methodology with particular
reference to the ease in obtaining the secondary out-
come measures. The data will be analysed to calculate
the completion rate of each outcome measure. A trial
steering committee will meet before, half way through,
and after the trial to discuss this feedback. The trial
management group will complete day to day monitor-
ing of the trial, consisting of the chief and principle
investigator, the clinical research nurse and the re-
search physiotherapists.
Feasibility of outcome measures
Swelling Circumference or girth of the knee has been
shown to have acceptable reliability for determination of
gross changes in knee swelling in patients post-surgery
[25]. Knee swelling is measured using the circumference
of the knee at the mid-portion of the patella with the
knee in full extension. Measurements are then taken 10
cm proximal to the superior pole of the patella (thigh)
and 10 cm distal to the inferior pole of the patella (calf ).
The skin is marked at these points and the tape measure
placed circumferentially around the limb, at and distal to
the level of the mark). Measurements are in centimetres
to one decimal place. Pre-operative values are taken on
the day of surgery, every post-operative day after ban-
dage removal until discharge and at 6-week follow-up.
Range of motion Active range of motion at the knee is
measured using a goniometer. The inter-tester reliability
and validity of this method previously have been shown
to be high [26]. The patient is positioned supine, with
the hip and knee in the neutral position. The femur is
stabilised to prevent rotation with a hand. The goniom-
eter is placed on the lateral epicondyle of the femur, with
the proximal arm on the lateral midline of the femur in
line with the greater trochanter, and the distal arm on
the lateral midline of the fibula in line with the lateral
malleolus. Active flexion and extension values are
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surgery, every post-operative day after bandage removal
until discharge and at 6-week follow-up.
Rest pain At-rest pain scores from 0 to 10 using a visual
analogue scale are assessed every day, prior to and after
physiotherapy in hospital. The visual analogue scale is a
simple and reliable method of recording pain and has
been validated in lower limb arthroplasty [27]. Pre-
operative values are taken on the day of surgery, and
further values assessed on every post-operative day
until discharge and at 6-week follow-up.
Patient reported outcome measures - knee pain and
function The Oxford knee score is a 12-point patient
reported outcome questionnaire specifically designed
and validated to assess function and pain after total knee
arthroplasty [28]. Each question is scored out of 5
points. A total score is calculated and referenced to clas-
sify joint function as mild, moderate or severely affected
by arthritis. This will be measured pre-operatively and at
six months.
Patient reported outcome measures - health status
The Euroqol EQ-5D questionnaire is a descriptive sys-
tem of health-related quality of life that can be applied
to different health conditions [29]. It consists of five di-
mensions (mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression) each of which takes
one of three responses for each dimension (no problems,
some problems, or severe problems). This will be mea-
sured pre-operatively and at 6 months.
Length of stay This is calculated from the patient’s ad-
mission and discharge dates and reflects midnights in
hospital.
Readmissions and complications Hospital episode stat-
istic data is used to calculate readmission rates. Compli-
cations attributed to the compression bandage, wound
complications and general medical complications within
30 days post-surgery will also be recorded.
Confounding factors
Whilst confounding factors have been limited where pos-
sible, potential factors include age, sex, co-morbidities,
pre-existing knee function, pre-existing chronic ven-
ous insufficiency, duration of operation, blood loss,
time of surgery and compliance with rehabilitation.
Pre-existing knee function and chronic venous insuffi-
ciency are however, in part, accounted for by taking
pre-operative knee measurements.Statistical analysis
A secure Excel database will be used to record data
(Microsoft Inc, Albuquerque, NM, USA). Statistical ana-
lysis will be performed using SPSS version 23.0 (SPSS
Inc, Chicago, IL, USA).
A power calculation will be performed based on the
mean and standard deviations of knee swelling values
collected from this preliminary data to inform a larger,
future trial. A treatment effect of a 3-cm reduction in
swelling based on previous literature will be used, utilis-
ing a 1-cm error of measurement and a 2-cm clinical
minimal relevance [19]. The risk of a type 1 error will be
set at 0.05 and a type II error at 0.20. The retention rate
from feasibility data will be incorporated into the final
sample size number to allow for possible patient drop-
out. The recruitment rate and resource allocation hours
can then also be applied to the final sample size required
to plan the future trial requirements.
For each outcome measure (knee swelling, range of
motion, visual analogue score, EQ-5D score, Oxford
knee score) the two groups will be compared at each
applicable set time point (pre-operative, day 1, day 2,
6 weeks, and 6 months). The difference from pre-
operative measurement will also be used to reduce the
impact of confounding factors between groups. A 95%
confidence interval of the group differences will be
calculated for each variable. A Kolmogorov-Smirnov
goodness of fit will be used to determine the distribu-
tion. If the distributions are equal, Student’s t-test for
independent samples will be used. The Welch correc-
tion will be used if variances are unequal. If the distri-
butions are unequal, the Mann-Whitney U test will be
used. Significance will be denoted at P <0.05.
Discussion
Enhanced recovery programmes in orthopaedic elective
surgery have been shown to significantly improve patient
length of stay and satisfaction [30]. The success of these
programmes can be attributed to utilising evidence-
based techniques and providing highly structured, co-
ordinated care. Despite their success, pathways should
constantly be scrutinised and updated in relation to
current best practice. Post-operative knee swelling and
pain is a potentially modifiable problem. It is associated
with short-term morbidity and has an unknown effect
on longer-term function [19].
Research regarding the use of compression bandages
in knee arthroplasty has been limited by a paucity of ro-
bust, clinical data. Small studies have shown improve-
ments in pain and range of motion, but further work is
required [16,17]. There is large heterogeneity in proto-
cols for total knee arthroplasty between surgeons and
hospitals, and therefore, independent variables are often
difficult to analyse. This trial aims to addresses this, by
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the trial methodology for a future, larger trial, and by
providing preliminary data regarding the efficacy of the
compression bandage using both objective and subject-
ive means.
We acknowledge limitations in the study. First, the
pressure at which the bandage is applied cannot be stan-
dardised without the use of a pressure transducer, which
would not be pragmatic for this trial. The bandage is de-
signed however, to ‘lock out’ at the desired tension for
application and, thus, will ensure similar application pa-
rameters between surgeons. Secondly, whilst visual
analogue scales will be used to measure pain, it is not
possible in this trial to standardise post-operative anal-
gesia as this is dependent on the patients’ demands,
allergies and co-morbidities. Finally, there is possible
inter-operator variation in measurement of the objective
outcomes such as range of motion and knee circumfer-
ence. However, where possible, validated outcome mea-
sures have been utilised, and the methodology designed
to reduce potential confounding factors.Trial status
The trial is currently recruiting patients. The first patients
enrolled in the study are at the 6-month follow-up.
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